Every publication devoted to innovation evokes a quiet temptation to present the latest platform as the answer and the limitations of the previous generation as problems solved. The articles in this issue of CRST Global resist that temptation, and that restraint increases their value. Across cataract and refractive surgery, the most meaningful advances are not simply raising the ceiling of what a single technology can do. They are also narrowing the distance between what we surgeons measure, what we plan, and what our patients experience.
Take corneal refractive surgery. Mark Lobanoff, MD, offers a candid single-surgeon perspective on ray tracing–guided LASIK. His most striking finding is not a higher proportion of patients with 20/10 UCVA but a reduction in his enhancement rate from 3.24% to 0.26%. As his golf analogy suggests, consistency, not the longest drive, wins the game. Luke Rebenitsch, MD, and Dan Z. Reinstein, MD, MA(Cantab), FRCSC, DABO, FRCOphth, FEBO, PGDip CRS, CertLRS, place keratorefractive lenticule extraction firmly within the mature refractive toolbox while moving beyond the either/or framing that often surrounds the procedure. Their shared message is worth remembering: the future lies not in flap versus flapless but in knowing when a given procedure is the right operation.
That same logic runs through the lens-based articles. In our contribution on phakic IOLs, Rex Hamilton, MD, MS, FACS, and I argue that modern posterior chamber phakic IOLs with central-port designs, improved vault prediction, and long-term endothelial safety data belong in the primary refractive conversation, not only after laser vision correction has been excluded. The expanded US FDA age indication for the EVO ICL (STAAR Surgical) and emerging low-profile designs for shallow and hyperopic eyes, such as the AmiLens Phakic (Amiplant), may broaden that conversation, although new designs will still have to earn their place through long-term data.
The refractive IOL series makes a parallel case. Eli L. Pratte, MD, and colleagues describe presbyopia-correcting lenses as a continuum rather than a set of categories. Jonathan Solomon, MD, FACS, shows how mix-and-match strategies turn IOL selection into binocular system design. Together, these articles shift the question from which lens is best to which evidence-supported option best matches a patient.
The roundtable of eight surgeons reinforces that direction. Modern IOL power calculations have improved predictability in eyes that once challenged even experienced surgeons, and the next frontier may be simulating how a specific optic will perform in a specific eye before surgery.
Two articles look further ahead. Uday Devgan, MD, FACS; Rajesh K. Rajpal, MD; and Cathleen M. McCabe, MD, discuss the first robot-assisted cataract procedures and frame robotics less as a precision upgrade for high-volume surgeons than as one potential response to gaps in the global workforce and surgical capacity. Whether that promise materializes will depend on evidence, cost, and workflow, and the authors are measured about all three. Finally, Steve A. Arshinoff, MD, FRCSC, and Runjie Bill Shi, PhD, bring a pharmacokinetic framework to drop-free cataract surgery. Their modeling supports a retained intracameral moxifloxacin dose of approximately 500 µg, delivered in a larger volume to improve reproducibility, and helps define when topical supplementation may still be warranted. Their work is a useful reminder that convenience and safety are related but distinct objectives.
What unites these contributions is a shared maturity. In this month’s cover series, the authors distinguish what has been demonstrated from what remains hypothetical. A recurring theme is that new technology should augment clinical judgment, not replace it. For European readers, whose regulatory pathways, reimbursement structures, and platform availability often differ from those in the United States, that discipline is especially relevant. The right choice depends on local context as much as on the device itself.
Innovation, in the end, is measured not by what we physicians can offer but by how well we match it to the person in front of us. I hope this issue helps you do exactly that.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
